AVDL logo

Avadel Pharmaceuticals plc (AVDL) Free cash flow

annual FCF:

-$46.91M+$81.60M(+63.50%)
December 31, 2024

Summary

  • As of today (September 17, 2025), AVDL annual free cash flow is -$46.91 million, with the most recent change of +$81.60 million (+63.50%) on December 31, 2024.
  • During the last 3 years, AVDL annual FCF has risen by +$30.43 million (+39.35%).
  • AVDL annual FCF is now -156.74% below its all-time high of $82.66 million, reached on December 31, 2015.

Performance

AVDL Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

quarterly FCF:

$12.68M+$20.91M(+254.05%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL quarterly free cash flow is $12.68 million, with the most recent change of +$20.91 million (+254.05%) on June 1, 2025.
  • Over the past year, AVDL quarterly FCF has increased by +$30.68 million (+170.47%).
  • AVDL quarterly FCF is now -49.36% below its all-time high of $25.04 million, reached on March 31, 2015.

Performance

AVDL quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

TTM FCF:

$5.89M+$30.68M(+123.77%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL TTM free cash flow is $5.89 million, with the most recent change of +$30.68 million (+123.77%) on June 1, 2025.
  • Over the past year, AVDL TTM FCF has increased by +$118.67 million (+105.22%).
  • AVDL TTM FCF is now -83.48% below its all-time high of $35.67 million, reached on June 30, 2017.

Performance

AVDL TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

AVDL Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.5%+170.5%+105.2%
3 y3 years+39.4%+172.3%+106.3%
5 y5 years-22.3%+263.1%+116.9%

AVDL Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+63.5%at high+133.0%at high+104.5%
5 y5-year-22.3%+63.5%at high+133.0%at high+104.5%
alltimeall time-156.7%+63.5%-49.4%+122.1%-83.5%+104.5%

AVDL Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$12.68M(-254.0%)
$5.89M(-123.8%)
Mar 2025
-
-$8.23M(-190.5%)
-$24.78M(-46.4%)
Dec 2024
-$46.91M(-63.5%)
$9.10M(-218.8%)
-$46.26M(-43.6%)
Sep 2024
-
-$7.65M(-57.5%)
-$81.98M(-27.3%)
Jun 2024
-
-$17.99M(-39.4%)
-$112.78M(-14.3%)
Mar 2024
-
-$29.70M(+11.6%)
-$131.64M(-0.4%)
Dec 2023
-$128.51M(+81.0%)
-$26.62M(-30.8%)
-$132.17M(+8.2%)
Sep 2023
-
-$38.45M(+4.3%)
-$122.17M(+37.1%)
Jun 2023
-
-$36.86M(+21.9%)
-$89.10M(+27.7%)
Mar 2023
-
-$30.23M(+81.8%)
-$69.78M(-5.2%)
Dec 2022
-$71.02M(-8.2%)
-$16.63M(+208.9%)
-$73.59M(-5.4%)
Sep 2022
-
-$5.38M(-69.3%)
-$77.80M(-16.1%)
Jun 2022
-
-$17.53M(-48.5%)
-$92.76M(+8.6%)
Mar 2022
-
-$34.05M(+63.4%)
-$85.39M(+14.2%)
Dec 2021
-$77.34M(+58.4%)
-$20.84M(+2.5%)
-$74.79M(+0.9%)
Sep 2021
-
-$20.34M(+100.0%)
-$74.15M(+13.6%)
Jun 2021
-
-$10.17M(-56.6%)
-$65.26M(+3.8%)
Mar 2021
-
-$23.44M(+16.0%)
-$62.87M(+23.1%)
Dec 2020
-$48.83M(+27.3%)
-$20.20M(+76.3%)
-$51.07M(+30.8%)
Sep 2020
-
-$11.46M(+47.3%)
-$39.05M(+12.3%)
Jun 2020
-
-$7.78M(-33.2%)
-$34.79M(+22.8%)
Mar 2020
-
-$11.64M(+42.2%)
-$28.34M(-25.3%)
Dec 2019
-$38.35M(-62.7%)
-$8.18M(+13.8%)
-$37.94M(-28.2%)
Sep 2019
-
-$7.19M(+441.1%)
-$52.84M(-18.6%)
Jun 2019
-
-$1.33M(-93.7%)
-$64.93M(-36.8%)
Mar 2019
-
-$21.24M(-8.0%)
-$102.71M(+3.2%)
Dec 2018
-$102.89M(+177.8%)
-$23.09M(+19.7%)
-$99.52M(+8.7%)
Sep 2018
-
-$19.28M(-50.7%)
-$91.53M(-29.4%)
Jun 2018
-
-$39.11M(+116.7%)
-$129.59M(+58.6%)
Mar 2018
-
-$18.05M(+19.5%)
-$81.69M(+111.3%)
Dec 2017
-$37.04M(-309.3%)
-$15.10M(-73.7%)
-$38.66M(+134.2%)
Sep 2017
-
-$57.33M(-751.9%)
-$16.51M(-146.3%)
Jun 2017
-
$8.80M(-64.8%)
$35.67M(+59.9%)
Mar 2017
-
$24.97M(+254.0%)
$22.31M(+29.4%)
Dec 2016
$17.70M(-78.6%)
$7.06M(-236.9%)
$17.24M(+69.3%)
Sep 2016
-
-$5.15M(+12.8%)
$10.19M(-33.6%)
Jun 2016
-
-$4.57M(-122.9%)
$15.34M(-22.9%)
Mar 2016
-
$19.91M(-20.5%)
$19.91M(+22.8%)
Dec 2015
$82.66M(-769.6%)
-
-
Mar 2015
-
$25.04M(-523.2%)
$16.21M(-239.4%)
Dec 2014
-$12.35M
-$5.92M(-310.5%)
-$11.63M(-13.6%)
Sep 2014
-
$2.81M(-149.1%)
-$13.45M(-20.3%)
Jun 2014
-
-$5.72M(+104.7%)
-$16.88M(-0.9%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$2.80M(-63.9%)
-$17.03M(-23.5%)
Dec 2013
-$21.70M(-10.3%)
-$7.74M(+1169.2%)
-$22.26M(+53.4%)
Sep 2013
-
-$610.10K(-89.6%)
-$14.51M(+4.4%)
Jun 2013
-
-$5.88M(-26.7%)
-$13.90M(-15.6%)
Mar 2013
-
-$8.02M(-5.0%)
-$16.47M(-13.3%)
Dec 2012
-$24.21M(+98.0%)
-
-
Jun 2012
-
-$8.45M(+71.6%)
-$19.00M(+64.7%)
Mar 2012
-
-$4.92M(+37.9%)
-$11.53M(-2.6%)
Dec 2011
-$12.23M(+35.0%)
-$3.57M(+73.0%)
-$11.84M(+30.4%)
Sep 2011
-
-$2.06M(+110.2%)
-$9.08M(+29.4%)
Jun 2011
-
-$981.30K(-81.2%)
-$7.02M(+16.3%)
Mar 2011
-
-$5.23M(+548.8%)
-$6.04M(+648.8%)
Dec 2010
-$9.06M(-240.9%)
-$806.30K(-70.9%)
-$806.30K(-97.5%)
Dec 2009
$6.42M(-158.2%)
-
-
Dec 2008
-$11.03M(-63.8%)
-
-
Dec 2007
-$30.51M(-15.8%)
-$2.77M(-68.4%)
-$32.27M(+9.4%)
Sep 2007
-
-$8.77M(-12.8%)
-$29.50M(+42.3%)
Jun 2007
-
-$10.05M(-5.9%)
-$20.73M(-6.7%)
Mar 2007
-
-$10.68M(-7.5%)
-$22.23M(-47.0%)
Dec 2006
-$36.22M(+17.9%)
-
-
Jun 2006
-
-$11.55M(+4.1%)
-$41.92M(+22.6%)
Mar 2006
-
-$11.10M(-3.6%)
-$34.18M(+16.3%)
Dec 2005
-$30.71M(+70.8%)
-$11.50M(+48.0%)
-$29.39M(+43.4%)
Sep 2005
-
-$7.77M(+104.1%)
-$20.50M(-11.5%)
Jun 2005
-
-$3.81M(-39.5%)
-$23.15M(-1.0%)
Mar 2005
-
-$6.30M(+140.9%)
-$23.39M(+30.0%)
Dec 2004
-$17.99M(-308.3%)
-$2.61M(-74.9%)
-$17.99M(+1100.5%)
Sep 2004
-
-$10.43M(+157.4%)
-$1.50M(-116.8%)
Jun 2004
-
-$4.05M(+352.1%)
$8.93M(-0.4%)
Mar 2004
-
-$896.00K(-106.5%)
$8.96M(+3.8%)
Dec 2003
$8.63M(+17.7%)
$13.87M(>+9900.0%)
$8.63M(-264.8%)
Sep 2003
-
$0.00(-100.0%)
-$5.24M(0.0%)
Jun 2003
-
-$4.02M(+228.1%)
-$5.24M(+328.1%)
Mar 2003
-
-$1.22M(+53.0%)
-$1.22M(+53.0%)
Dec 2002
$7.34M(-285.2%)
-
-
Dec 2001
-$3.96M(-37.7%)
-
-
Dec 2000
-$6.36M(+29.5%)
-
-
Dec 1999
-$4.91M(-47.3%)
-
-
Dec 1998
-$9.32M(-11.2%)
-
-
Mar 1998
-
-$800.00K(-366.7%)
-$800.00K(-366.7%)
Dec 1997
-$10.50M(+84.2%)
-
-
Dec 1996
-$5.70M
-
-
Mar 1996
-
$300.00K
$300.00K

FAQ

  • What is Avadel Pharmaceuticals plc annual free cash flow?
  • What is the all time high annual FCF for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual FCF year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly free cash flow?
  • What is the all time high quarterly FCF for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly FCF year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM free cash flow?
  • What is the all time high TTM FCF for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM FCF year-on-year change?

What is Avadel Pharmaceuticals plc annual free cash flow?

The current annual FCF of AVDL is -$46.91M

What is the all time high annual FCF for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual free cash flow is $82.66M

What is Avadel Pharmaceuticals plc annual FCF year-on-year change?

Over the past year, AVDL annual free cash flow has changed by +$81.60M (+63.50%)

What is Avadel Pharmaceuticals plc quarterly free cash flow?

The current quarterly FCF of AVDL is $12.68M

What is the all time high quarterly FCF for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly free cash flow is $25.04M

What is Avadel Pharmaceuticals plc quarterly FCF year-on-year change?

Over the past year, AVDL quarterly free cash flow has changed by +$30.68M (+170.47%)

What is Avadel Pharmaceuticals plc TTM free cash flow?

The current TTM FCF of AVDL is $5.89M

What is the all time high TTM FCF for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM free cash flow is $35.67M

What is Avadel Pharmaceuticals plc TTM FCF year-on-year change?

Over the past year, AVDL TTM free cash flow has changed by +$118.67M (+105.22%)
On this page